Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Surufatinib(HMPL-012)
DRUG
2 trials
Sponsors
Fujian Cancer Hospital
Conditions
Advanced Colorectal Cancer
Nasopharyngeal Carcinoma
Phase 2
Second-line Surufatinib Combined With Chemotherapy in Advanced CRC
NCT04734249
Fujian Cancer Hospital
Advanced Colorectal Cancer
Start: 2021-03-31
End: 2023-12-31
Target: 56
Updated: 2021-02-02
Surufatinib Combined With Toripalimab in Recurrent or Metastatic Nasopharyngeal Carcinoma
NCT04955886
Fujian Cancer Hospital
Nasopharyngeal Carcinoma
Start: 2021-08-31
End: 2023-08-31
Target: 14
Updated: 2021-07-09
Related Papers
Randomized phase-II trial of surufatinib plus FOLFOX/FOLFIRI versus FOLFOXIRI as second-line therapy for metastatic colorectal cancer.
2026-07-09